Impaired skeletal muscle β-adrenergic activation and lipolysis are associated with whole-body insulin resistance in rats bred for low intrinsic exercise capacity

Endocrinology

Volumn 150, Issue 11, 2009, Pages 4883-4891

  Lessard, Sarah J ^a   Rivas, Donato A ^a   Chen, Zhi Ping ^b   Van Denderen, Bryce J ^b   Watt, Matthew J ^c   Koch, Lauren G ^d   Britton, Steven L ^d   Kemp, Bruce E ^b   Hawley, John A ^a  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CD36 ANTIGEN; CERAMIDE; DIACYLGLYCEROL; GLUCOSE; ISOPRENALINE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 3;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIPOLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE;

ADRENERGIC BETA-AGONISTS; ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; EXERCISE; GENE EXPRESSION; HUMANS; HYBRIDIZATION, GENETIC; INSULIN RESISTANCE; ISOPROTERENOL; LIPOLYSIS; MALE; MUSCLE, SKELETAL; PHYSICAL ENDURANCE; RATS; RECEPTORS, ADRENERGIC, BETA-2; RUNNING; SIGNAL TRANSDUCTION;

EID: 70350326027     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0158     Document Type: Article

References (56)

1. Houmard JA, Tanner CJ, Slentz CA, Duscha BD, McCartney JS, Kraus WE 2004 Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol 96:101-106 (Pubitemid 38031988)
2. Pedersen BK, Saltin B 2006 Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 16(Suppl 1):3-63
3. Hawley JA, Lessard SJ 2008 Exercise training-induced improvements in insulin action. Acta Physiol (Oxf) 192:127-135
4. Wisløff U, Najjar SM, Ellingsen O, Haram PM, Swoap S, Al-Share Q, Fernström M, Rezaei K, Lee SJ, Koch LG, Britton SL 2005 Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307:418-420 (Pubitemid 40139985)
5. Noland RC, Thyfault JP, Henes ST, Whitfield BR, Woodlief TL, Evans JR, Lust JA, Britton SL, Koch LG, Dudek RW, Dohm GL, Cortright RN, Lust RM 2007 Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance. Am J Physiol Endocrinol Metab 293:E31-E41
6. Bruce CR, Thrush AB, Mertz VA, Bezaire V, Chabowski A, Heigenhauser GJ, Dyck DJ 2006 Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291:E99-E107 (Pubitemid 44035314)
7. Frøsig C, Jørgensen SB, Hardie DG, Richter EA, Wojtaszewski JF 2004 5′-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle. Am J Physiol Endocrinol Metab 286:E411-E417 (Pubitemid 38292691)
8. Frøsig C, Rose AJ, Treebak JT, Kiens B, Richter EA, Wojtaszewski JF 2007 Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160. Diabetes 56:2093-2102 (Pubitemid 47195824)
9. Sriwijitkamol A, Ivy JL, Christ-Roberts C, DeFronzo RA, Mandarino LJ, Musi N 2006 LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training. Am J Physiol Endocrinol Metab 290:E925-932
10. Wojtaszewski JF, Birk JB, Frøsig C, Holten M, Pilegaard H, Dela F 2005 5′ AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes. J Physiol 564:563-573 (Pubitemid 40585054)
11. Kjaer M 1998 Adrenal medulla and exercise training. Eur J Appl Physiol Occup Physiol 77:195-199
12. Zouhal H, Jacob C, Delamarche P, Gratas-Delamarche A 2008 Catecholamines and the effects of exercise, training and gender. Sports Med 38:401-423 (Pubitemid 351550538)
13. Mulder H, Sörhede-Winzell M, Contreras JA, Fex M, Ström K, Ploug T, Galbo H, Arner P, Lundberg C, Sundler F, Ahrén B, Holm C 2003 Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. J Biol Chem 278:36380-36388 (Pubitemid 37139966)
14. Chabowski A, Momken I, Coort SL, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Bonen A 2006 Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts. Mol Cell Biochem 288:201-212 (Pubitemid 44314455)
15. Maxwell MA, Cleasby ME, Harding A, Stark A, Cooney GJ, Muscat GE 2005 Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J Biol Chem 280:12573-12584 (Pubitemid 40491075)
16. Koch LG, Britton SL 2001 Artificial selection for intrinsic aerobic endurance running capacity in rats. Physiol Genomics 5:45-52
17. Lessard SJ, Lo Giudice SL, Lau W, Reid JJ, Turner N, Febbraio MA, Hawley JA, Watt MJ 2004 Rosiglitazone enhances glucose tolerance by mechanisms other than reduction of fatty acid accumulation within skeletal muscle. Endocrinology 145:5665-5670 (Pubitemid 39564608)
18. Lessard SJ, Chen ZP, Watt MJ, Hashem M, Reid JJ, Febbraio MA, Kemp BE, Hawley JA 2006 Chronic rosiglitazone treatment restores AMPKα2 activity in insulin-resistant rat skeletal muscle. Am J Physiol Endocrinol Metab 290:E251-E257
19. Chen Z, Heierhorst J, Mann RJ, Mitchelhill KI, Michell BJ, Witters LA, Lynch GS, Kemp BE, Stapleton D 1999 Expression of the AMP-activated protein kinase β1 and β2 subunits in skeletal muscle. FEBS Lett 460:343-348 (Pubitemid 29495966)
20. Enoksson S, Hagström-Toft E, Nordahl J, Hultenby K, Pettersson N, Isaksson B, Permert J, Wibom R, Holm C, Bolinder J, Arner P 2005 Marked reutilization of free fatty acids during activated lipolysis in human skeletal muscle. J Clin Endocrinol Metab 90:1189-1195 (Pubitemid 40279253)
21. Watt MJ, Stellingwerff T, Heigenhauser GJ, Spriet LL 2003 Effects of plasma adrenaline on hormone-sensitive lipase at rest and during moderate exercise in human skeletal muscle. J Physiol 550:325-332 (Pubitemid 36869291)
22. Kelley DE, Goodpaster BH, Storlien L 2002 Muscle triglyceride and insulin resistance. Annu Rev Nutr 22:325-346
23. Goodpaster BH, He J, Watkins S, Kelley DE 2001 Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance- trained athletes. J Clin Endocrinol Metab 86:5755-5761 (Pubitemid 33152620)
24. Bruce CR, Kriketos AD, Cooney GJ, Hawley JA 2004 Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 47:23-30 (Pubitemid 38141936)
25. Lessard SJ, Rivas DA, Chen ZP, Bonen A, Febbraio MA, Reeder DW, Kemp BE, Yaspelkis 3rd BB, Hawley JA 2007 Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance. Diabetes 56:1856-1864
26. Horowitz JF 2007 Exercise-induced alterations in muscle lipid metabolism improve insulin sensitivity. Exerc Sport Sci Rev 35:192-196
27. Schenk S, Horowitz JF 2007 Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 117:1690-1698 (Pubitemid 46871353)
28. Jessen N, Pold R, Buhl ES, Jensen LS, Schmitz O, Lund S 2003 Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. J Appl Physiol 94:1373-1379 (Pubitemid 36348812)
29. Pold R, Jensen LS, Jessen N, Buhl ES, Schmitz O, Flyvbjerg A, Fujii N, Goodyear LJ, Gotfredsen CF, Brand CL, Lund S 2005 Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54:928-934 (Pubitemid 40446305)
30. Kramer HF, Witczak CA, Fujii N, Jessen N, Taylor EB, Arnolds DE, Sakamoto K, Hirshman MF, Goodyear LJ 2006 Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55:2067-2076
31. Treebak JT, Birk JB, Rose AJ, Kiens B, Richter EA, Wojtaszewski JF 2007 AS160 phosphorylation is associated with activation of α2β2γ1- but not α2β2γ3-AMPK trimeric complex in skeletal muscle during exercise in humans. Am J Physiol 292:E715-E722
32. Winder WW, Thompson DM 2008 AMPK: the master switch for type 2 diabetes? In: Hawley JA, Zierath JR, eds. Physical activity and type 2 diabetes: therapeutic effects and mechanisms of action. Champaign, IL: Human Kinetics; 177-185
33. Deshmukh AS, Treebak JT, Long YC, Viollet B, Wojtaszewski JF, Zierath JR 2008 Role of adenosine 5′-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling. Mol Endocrinol 22:1105-1112 (Pubitemid 351629611)
34. Yu H, Hirshman MF, Fujii N, Pomerleau JM, Peter LE, Goodyear LJ 2006 Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase γ3-subunit differentially regulates glycogen accumulation. Am J Physiol 291:E557-E565
35. Sable DL, Brammell HL, Sheehan MW, Nies AS, Gerber J, Horwitz LD 1982 Attenuation of exercise conditioning by β-adrenergic blockade. Circulation 65:679-684
36. Ji LL, Lennon DL, Kochan RG, Nagle FJ, Lardy HA 1986 Enzymatic adaptation to physical training under β-blockade in the rat. Evidence of a β2-adrenergic mechanism in skeletal muscle. J Clin Invest 78:771-778
37. Buckenmeyer PJ, Goldfarb AH, Partilla JS, Piñeyro MA, Dax EM 1990 Endurance training, not acute exercise, differentially alters β-receptors and cyclase in skeletal fiber types. Am J Physiol 258: E71-E77
38. Plourde G, Rousseau-Migneron S, Nadeau A 1993 Effect of endurance training on β-adrenergic system in three different skeletal muscles. J Appl Physiol 74:1641-1646 (Pubitemid 23133453)
39. Jocken JW, Blaak EE 2008 Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiol Behav 94:219-230
40. Hurley RL, Barré LK, Wood SD, Anderson KA, Kemp BE, Means AR, Witters LA 2006 Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J Biol Chem 281:36662-36672
41. Takahashi A, Tabuchi M, Suzuki W, Iizuka S, Nagata M, Ikeya Y, Takeda S, Shimada T, Aburada M 2006 Insulin resistance and low sympathetic nerve activity in the Tsumura Suzuki obese diabetic mouse: a new model of spontaneous type 2 diabetes mellitus and obesity. Metabolism 55:1664-1669 (Pubitemid 44827134)
42. Pacak K, McCarty R, Palkovits M, Cizza G, Kopin IJ, Goldstein DS, Chrousos GP 1995 Decreased central and peripheral catecholaminergic activation in obese Zucker rats. Endocrinology 136:4360-4367
43. Blaak EE, Schiffelers SL, Saris WH, Mensink M, Kooi ME 2004 Impaired β-adrenergically mediated lipolysis in skeletal muscle of obese subjects. Diabetologia 47:1462-1468 (Pubitemid 39232433)
44. 2-adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. J Clin Endocrinol Metab 86:2191-2199
45. Jocken JW, Blaak EE, Schiffelers S, Arner P, van Baak MA, Saris WH 2007 Association of a β-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation. Int J Obes (Lond) 31:813-819 (Pubitemid 46663821)
46. Jocken JW, Blaak EE, van der Kallen CJ, van Baak MA, Saris WH 2008 Blunted β-adrenoceptor-mediated fat oxidation in overweight subjects: a role for the hormone-sensitive lipase gene. Metabolism 57:326-332
47. Howlett RA, Gonzalez NC, Wagner HE, Fu Z, Britton SL, Koch LG, Wagner PD 2003 Selected contribution: skeletal muscle capillarity and enzyme activity in rats selectively bred for running endurance. J Appl Physiol 94:1682-1688
48. Chao LC, Zhang Z, Pei L, Saito T, Tontonoz P, Pilch PF 2007 Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol Endocrinol 21:2152-2163 (Pubitemid 47347379)
49. Smith AG, Muscat GE 2006 Orphan nuclear receptors: therapeutic opportunities in skeletal muscle. Am J Physiol Cell Physiol 291:C203-C217
50. Fu Y, Luo L, Luo N, Zhu X, Garvey WT 2007 NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance. J Biol Chem 282:31525-31533 (Pubitemid 350044839)
51. Mahoney DJ, Parise G, Melov S, Safdar A, Tarnopolsky MA 2005 Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J 19:1498-1500 (Pubitemid 41279010)
52. Mensink M, Hesselink MK, Borghouts LB, Keizer H, Moonen-Kornips E, Schaart G, Blaak EE, Schrauwen P 2007 Skeletal muscle uncoupling protein-3 restores upon intervention in the prediabetic and diabetic state: implications for diabetes pathogenesis? Diabetes Obes Metab 9:594-596
53. Choi CS, Fillmore JJ, Kim JK, Liu ZX, Kim S, Collier EF, Kulkarni A, Distefano A, Hwang YJ, Kahn M, Chen Y, Yu C, Moore IK, Reznick RM, Higashimori T, Shulman GI 2007 Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. J Clin Invest 117:1995-2003 (Pubitemid 47036334)
54. Holloway GP, Bezaire V, Heigenhauser GJ, Tandon NN, Glatz JF, Luiken JJ, Bonen A, Spriet LL 2006 Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J Physiol 571:201-210
55. Héron-Milhavet L, Haluzik M, Yakar S, Gavrilova O, Pack S, Jou WC, Ibrahimi A, Kim H, Hunt D, Yau D, Asghar Z, Joseph J, Wheeler MB, Abumrad NA, LeRoith D 2004 Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice. Endocrinology 145:4667-4676 (Pubitemid 39281460)
56. Bastie CC, Hajri T, Drover VA, Grimaldi PA, Abumrad NA 2004 CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness. Diabetes 53:2209-2216 (Pubitemid 39145573)